tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF Screener
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Newsletter Center
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

DAWN Stock Latest News

CORRECTION — Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Press ReleasesCORRECTION — Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
2d ago
DAWN
Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Press ReleasesDay One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
2d ago
DAWN
Day One language around NDA submission ‘sounded ominous,’ says Oppenheimer
The FlyDay One language around NDA submission ‘sounded ominous,’ says Oppenheimer
26d ago
DAWN
Day One pullback brings attractive entry point, says H.C. Wainwright
The FlyDay One pullback brings attractive entry point, says H.C. Wainwright
26d ago
DAWN
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
Press ReleasesDay One Reports First Quarter 2023 Financial Results and Corporate Progress
26d ago
DAWN
Day One Biopharmaceuticals reports Q1 EPS (59c), consensus (59c)
The FlyDay One Biopharmaceuticals reports Q1 EPS (59c), consensus (59c)
26d ago
DAWN
Buy/Sell: Wall Street’s top 10 stock calls this week
The FlyBuy/Sell: Wall Street’s top 10 stock calls this week
29d ago
ADCT
ATVI
Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Press ReleasesDay One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
1M ago
DAWN
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
1M ago
AFL
ARGX
Day One Biopharmaceuticals double downgraded at BofA on regulatory risks
The FlyDay One Biopharmaceuticals double downgraded at BofA on regulatory risks
1M ago
DAWN
Day One Biopharmaceuticals downgraded to Underperform from Buy at BofA
The FlyDay One Biopharmaceuticals downgraded to Underperform from Buy at BofA
1M ago
DAWN
Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
Press ReleasesDay One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
2M ago
DAWN
JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
The FlyJPMorgan SMid cap biotech analyst to hold analyst/industry conference call
2M ago
DAWN
JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
The FlyJPMorgan SMid cap biotech analyst to hold analyst/industry conference call
2M ago
DAWN
Day One Biopharmaceuticals price target lowered to $44 from $48 at Needham
The FlyDay One Biopharmaceuticals price target lowered to $44 from $48 at Needham
2M ago
DAWN
Oppenheimer still not a buyer of Day One Biopharmaceuticals despite selloff
The FlyOppenheimer still not a buyer of Day One Biopharmaceuticals despite selloff
2M ago
DAWN
Day One not changing endpoint for FIREFLY-1 trial, says JonesResearch
The FlyDay One not changing endpoint for FIREFLY-1 trial, says JonesResearch
2M ago
DAWN
Day One FIREFLY-2 update brings two possible issues, says Oppenheimer
The FlyDay One FIREFLY-2 update brings two possible issues, says Oppenheimer
2M ago
DAWN
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
Press ReleasesDay One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
3M ago
DAWN
Day One to Participate in the Cowen 43rd Annual Health Care Conference
Press ReleasesDay One to Participate in the Cowen 43rd Annual Health Care Conference
3M ago
DAWN
Billionaire Steve Cohen Pulls the Trigger on These 2 ‘Strong Buy’ Stocks
Stock Analysis & IdeasBillionaire Steve Cohen Pulls the Trigger on These 2 ‘Strong Buy’ Stocks
3M ago
DAWN
MRNS
Day One Biopharmaceuticals initiated with an Overweight at Capital One
The FlyDay One Biopharmaceuticals initiated with an Overweight at Capital One
4M ago
DAWN